** Shares of medical equipment maker West Pharmaceutical Services WST.N fall 14.01% to $277.13 premarket
** Co sees 2025 adj profit between $6 and $6.20 per share, missing analysts avg estimate of $7.44 per share - LSEG
** Sees 2025 sales between $2.88 bln and $2.91 bln, below estimates of $3.04 bln
** Posts Q4 adj profit of $1.82 per share vs analysts avg estimate of $1.72 per share
** Posts Q4 sales of $748.8 mln vs analysts avg estimate of $740.47 mln
** In the last 12 months, WST has fallen ~21%
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。